1. Home
  2. CISO vs INTS Comparison

CISO vs INTS Comparison

Compare CISO & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CISO
  • INTS
  • Stock Information
  • Founded
  • CISO 2015
  • INTS 2012
  • Country
  • CISO United States
  • INTS United States
  • Employees
  • CISO N/A
  • INTS N/A
  • Industry
  • CISO Computer Software: Prepackaged Software
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CISO Technology
  • INTS Health Care
  • Exchange
  • CISO Nasdaq
  • INTS Nasdaq
  • Market Cap
  • CISO 32.7M
  • INTS 33.4M
  • IPO Year
  • CISO N/A
  • INTS 2023
  • Fundamental
  • Price
  • CISO $1.04
  • INTS $2.17
  • Analyst Decision
  • CISO
  • INTS Strong Buy
  • Analyst Count
  • CISO 0
  • INTS 3
  • Target Price
  • CISO N/A
  • INTS $8.50
  • AVG Volume (30 Days)
  • CISO 117.1K
  • INTS 32.4K
  • Earning Date
  • CISO 11-18-2024
  • INTS 03-13-2025
  • Dividend Yield
  • CISO N/A
  • INTS N/A
  • EPS Growth
  • CISO N/A
  • INTS N/A
  • EPS
  • CISO N/A
  • INTS N/A
  • Revenue
  • CISO $54,633,909.00
  • INTS N/A
  • Revenue This Year
  • CISO $78.76
  • INTS N/A
  • Revenue Next Year
  • CISO N/A
  • INTS N/A
  • P/E Ratio
  • CISO N/A
  • INTS N/A
  • Revenue Growth
  • CISO 34.87
  • INTS N/A
  • 52 Week Low
  • CISO $0.26
  • INTS $1.50
  • 52 Week High
  • CISO $3.84
  • INTS $5.94
  • Technical
  • Relative Strength Index (RSI)
  • CISO 42.23
  • INTS 44.33
  • Support Level
  • CISO $0.96
  • INTS $1.84
  • Resistance Level
  • CISO $1.03
  • INTS $2.53
  • Average True Range (ATR)
  • CISO 0.08
  • INTS 0.32
  • MACD
  • CISO 0.03
  • INTS -0.02
  • Stochastic Oscillator
  • CISO 68.88
  • INTS 45.83

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

Share on Social Networks: